These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27393544)

  • 1. 'They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan.
    Stringer B; Lowton K; Tillashaikhov M; Parpieva N; Ulmasova D; du Cros P; Hasker E; Sergeeva N
    Int J Tuberc Lung Dis; 2016 Aug; 20(8):1084-90. PubMed ID: 27393544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Where there is hope: a qualitative study examining patients' adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan.
    Horter S; Stringer B; Greig J; Amangeldiev A; Tillashaikhov MN; Parpieva N; Tigay Z; du Cros P
    BMC Infect Dis; 2016 Jul; 16():362. PubMed ID: 27465783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan.
    Horter S; Stringer B; Gray N; Parpieva N; Safaev K; Tigay Z; Singh J; Achar J
    BMC Infect Dis; 2020 Sep; 20(1):675. PubMed ID: 32938422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan.
    Horter S; Achar J; Gray N; Parpieva N; Tigay Z; Singh J; Stringer B
    PLoS One; 2020; 15(11):e0242359. PubMed ID: 33237960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'I cry every day': experiences of patients co-infected with HIV and multidrug-resistant tuberculosis.
    Isaakidis P; Rangan S; Pradhan A; Ladomirska J; Reid T; Kielmann K
    Trop Med Int Health; 2013 Sep; 18(9):1128-1133. PubMed ID: 23837468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving outcomes for multi-drug-resistant tuberculosis in the Peruvian Amazon - a qualitative study exploring the experiences and perceptions of patients and healthcare professionals.
    McNally TW; de Wildt G; Meza G; Wiskin CMD
    BMC Health Serv Res; 2019 Aug; 19(1):594. PubMed ID: 31438958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'I'm fed up': experiences of prior anti-tuberculosis treatment in patients with drug-resistant tuberculosis and HIV.
    Furin J; Isaakidis P; Reid AJ; Kielmann K
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1479-84. PubMed ID: 25517815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant tuberculosis in central Asia.
    Cox HS; Orozco JD; Male R; Ruesch-Gerdes S; Falzon D; Small I; Doshetov D; Kebede Y; Aziz M
    Emerg Infect Dis; 2004 May; 10(5):865-72. PubMed ID: 15200821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan.
    Trauer JM; Achar J; Parpieva N; Khamraev A; Denholm JT; Falzon D; Jaramillo E; Mesic A; du Cros P; McBryde ES
    BMC Med; 2016 Nov; 14(1):187. PubMed ID: 27855693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "My Favourite Day Is Sunday": Community Perceptions of (Drug-Resistant) Tuberculosis and Ambulatory Tuberculosis Care in Kara Suu District, Osh Province, Kyrgyzstan.
    Burtscher D; Van den Bergh R; Toktosunov U; Angmo N; Samieva N; Rocillo Arechaga EP
    PLoS One; 2016; 11(3):e0152283. PubMed ID: 27019454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient and health-care provider experience of a person-centred, multidisciplinary, psychosocial support and harm reduction programme for patients with harmful use of alcohol and drug-resistant tuberculosis in Minsk, Belarus.
    Harrison RE; Shyleika V; Falkenstein C; Garsevanidze E; Vishnevskaya O; Lonnroth K; Sayakci Ö; Sinha A; Sitali N; Skrahina A; Stringer B; Tan C; Mar HT; Venis S; Vetushko D; Viney K; Vishneuski R; Carrion Martin AI
    BMC Health Serv Res; 2022 Sep; 22(1):1217. PubMed ID: 36180873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of multidrug-resistant tuberculosis in a remote, conflict-affected area of the Democratic Republic of Congo.
    Shanks L; Masumbuko EW; Ngoy NM; Maneno M; Bartlett S; Thi SS; Shah T
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):1066-8. PubMed ID: 22565108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Home is where the patient is": a qualitative analysis of a patient-centred model of care for multi-drug resistant tuberculosis.
    Horter S; Stringer B; Reynolds L; Shoaib M; Kasozi S; Casas EC; Verputten M; du Cros P
    BMC Health Serv Res; 2014 Feb; 14():81. PubMed ID: 24559177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-sectional study about knowledge and attitudes toward multidrug-resistant and extensively drug-resistant tuberculosis in a high-burden drug-resistant country.
    Javed H; Tahir Z; Hashmi HJ; Jamil N
    Int J Mycobacteriol; 2016 Jun; 5(2):128-34. PubMed ID: 27242222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing adherence to tuberculosis treatment in Asmara, Eritrea: a qualitative study.
    Gebreweld FH; Kifle MM; Gebremicheal FE; Simel LL; Gezae MM; Ghebreyesus SS; Mengsteab YT; Wahd NG
    J Health Popul Nutr; 2018 Jan; 37(1):1. PubMed ID: 29304840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Ecuador's national monetary incentive program on adherence to treatment for drug-resistant tuberculosis.
    Sripad A; Castedo J; Danford N; Zaha R; Freile C
    Int J Tuberc Lung Dis; 2014 Jan; 18(1):44-8. PubMed ID: 24365551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'I didn't know so many people cared about me': support for patients who interrupt drug-resistant TB treatment.
    Snyman L; Venables E; Trivino Duran L; Mohr E; Azevedo VD; Harmans X; Isaakidis P
    Int J Tuberc Lung Dis; 2018 Sep; 22(9):1023-1030. PubMed ID: 30092867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with default from multi- and extensively drug-resistant tuberculosis treatment, Uzbekistan: a retrospective cohort analysis.
    Lalor MK; Greig J; Allamuratova S; Althomsons S; Tigay Z; Khaemraev A; Braker K; Telnov O; du Cros P
    PLoS One; 2013; 8(11):e78364. PubMed ID: 24223148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers.
    Thomas BE; Kumar JV; Periyasamy M; Khandewale AS; Hephzibah Mercy J; Raj EM; Kokila S; Walgude AS; Gaurkhede GR; Kumbhar JD; Ovung S; Paul M; Rajkumar BS; Subbaraman R
    J Med Internet Res; 2021 Jun; 23(6):e23294. PubMed ID: 34110300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated with Unfavourable Treatment Outcomes in Patients with Tuberculosis: A 16-Year Cohort Study (2005-2020), Republic of Karakalpakstan, Uzbekistan.
    Gadoev J; Asadov D; Harries AD; Kumar AMV; Boeree MJ; Hovhannesyan A; Kuppens L; Yedilbayev A; Korotych O; Hamraev A; Kudaybergenov K; Abdusamatova B; Khudanov B; Dara M
    Int J Environ Res Public Health; 2021 Dec; 18(23):. PubMed ID: 34886554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.